Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 1,960 | 1,532 | 1,674 | 2,798 | 6,029 |
| Operating Income | -1,960 | -1,532 | -1,674 | -2,798 | -6,029 |
| Interest Expense | 10 | 12 | 13 | 14 | 15 |
| Other Income | 26 | 19 | 28 | -3 | 22 |
| Pre-tax Income | -1,944 | -1,525 | -1,659 | -2,816 | -6,023 |
| Net Income Continuous | -1,944 | -1,525 | -1,659 | -2,816 | -6,023 |
| Net Income | $-1,944 | $-1,525 | $-1,659 | $-2,816 | $-6,023 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.02 |
| EBITDA(a) | $-1,934 | $-1,513 | $-1,646 | $-2,801 | $-6,008 |